SCHEMBL13488282

SCHEMBL13488282

Cc1ccc2c(-c3ccccc3)c3ccccc3c(-c3ccc4c(c3)N(C)c3ccccc3CC4)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 1/20 0.38
LMNA P02545 5/20 0.34
HTT P42858 3/20 0.34
MAPT P10636 3/20 0.34
KDM4E B2RXH2 2/20 0.34
KMT2A Q03164 2/20 0.34
SMN1; SMN2 Q16637 4/20 0.33
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
PTGS2 P35354 2/20 0.33
NPSR1 Q6W5P4 2/20 0.33
NPY1R P25929 1/20 0.33
NPY2R P49146 1/20 0.33
ALDH1A1 P00352 3/20 0.33
POLB P06746 3/20 0.33
MAPK8 P45983 1/20 0.32
CDK4 P11802 1/20 0.32
CCND1 P24385 1/20 0.32
MEN1 O00255 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13488287 0.99 HSD17B3 (0.39) HSD17B3LMNAHTTMAPTKDM4E
SCHEMBL13488293 0.93 ALDH1A1 (0.34) LMNAHTTMAPTKDM4EKMT2A
SCHEMBL13488300 0.92 HTR2A (0.35) HSD17B3LMNAHTTKDM4EKMT2A
SCHEMBL13488283 0.90 AKT1 (0.38) HSD17B3LMNAHTTMAPTKDM4E
SCHEMBL13488289 0.87 CYP11B1 (0.35) LMNAHTTMAPTKDM4EKMT2A
SCHEMBL13488285 0.87 CYP11B1 (0.37) LMNAHTTMAPTKDM4EKMT2A
SCHEMBL13488313 0.86 PTGS2 (0.38) LMNAHTTMAPTKDM4EKMT2A
SCHEMBL13488584 0.85 CYP11B1 (0.30)
SCHEMBL13488319 0.84 PTGS2 (0.37) LMNAHTTMAPTKDM4EKMT2A
SCHEMBL13487864 0.84 PDK2 (0.32) LMNAHTTMAPTKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
EP-2108689-A2 Novel organic electroluminescent compounds and organic electroluminescent device using the same Gracel Display Inc. (KR) 2009-10-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 HSD17B3 1499/4885LMNA 3760/4885HTT 3379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.